Robert Segraves, MD

MetroHealth SystemCleveland, Ohio - 44122 (216-778-3871) MetroHealth Medical CenterCleveland, Ohio - 44109 (216-778-2223) |
- CLINICAL TRIALS 4
- CONDITIONS4
- INTERVENTIONS5
- SINCE2009

Lurasidone - A 6-week Study of Patients With Bipolar I Depression (Add-on)
April 2009 - September 2011

Efficacy Safety and Tolerability of Agomelatine Sublingual Tablets in the Treatment of Major Depressive Disorder (MDD)
May 2010 - July 2011

Lurasidone - A 24-week Extension Study of Patients With Bipolar I Depression
April 2009 - February 2012

Lurasidone - A 6-week Study of Patients With Bipolar I Depression (Monotherapy)
April 2009 - September 2010
Depression
Depressive Disorder
Depressive Disorder, Major
Bipolar Disorder
Placebo
Lurasidone + (Lithium Or Divalproex)
Placebo + (Lithium Or Divalproex)
Agomelatine (Ago178c)
Lurasidone



